Literature DB >> 18992615

Prognostic models and algorithms in renal cell carcinoma.

Brian R Lane1, Michael W Kattan.   

Abstract

Although surgical treatment is curative for localized renal cell carcinoma (RCC), 25% of patients present with locally advanced or disseminated disease, and disease will recur systemically in another 20% to 30% of those who have localized disease at presentation. Many clinical, histologic, and molecular factors have been identified that place patients who have localized RCC at greater risk for recurrence and those who have metastatic disease at risk for progression or death. This article reviews the major prognostic factors for RCC and the most commonly used algorithms developed for use before or after nephrectomy and before initiation of systemic therapy. These RCC nomograms allow more accurate counseling of patients regarding their likely clinical course and facilitate treatment planning.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992615     DOI: 10.1016/j.ucl.2008.07.003

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  27 in total

Review 1.  Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy.

Authors:  E Jason Abel; Christopher G Wood
Journal:  Nat Rev Urol       Date:  2009-06-16       Impact factor: 14.432

2.  Pathological characteristics and radiographic correlates of complex renal cysts.

Authors:  Adam C Reese; Pamela T Johnson; Michael A Gorin; Phillip M Pierorazio; Mohamad E Allaf; Elliot K Fishman; George J Netto; Christian P Pavlovich
Journal:  Urol Oncol       Date:  2014-07-09       Impact factor: 3.498

Review 3.  Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinoma.

Authors:  Bernard Escudier; Laurence Albiges
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

4.  Factors affecting the time to recurrence after radical nephrectomy for localized renal cell carcinoma.

Authors:  Hee-Seo Son; Seung Hyun Jeon; Sung-Goo Chang
Journal:  Korean J Urol       Date:  2013-11-06

Review 5.  Emerging critical role of molecular testing in diagnostic genitourinary pathology.

Authors:  George J Netto; Liang Cheng
Journal:  Arch Pathol Lab Med       Date:  2012-04       Impact factor: 5.534

6.  Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.

Authors:  Todd M Morgan; Dominic Tang; Kelly L Stratton; Daniel A Barocas; Christopher B Anderson; Justin R Gregg; Sam S Chang; Michael S Cookson; S Duke Herrell; Joseph A Smith; Peter E Clark
Journal:  Eur Urol       Date:  2011-01-28       Impact factor: 20.096

Review 7.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

8.  Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein.

Authors:  S P K Jagdev; W Gregory; N S Vasudev; P Harnden; S Sim; D Thompson; J Cartledge; P J Selby; R E Banks
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

9.  Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer.

Authors:  S L Wood; M Rogers; D A Cairns; A Paul; D Thompson; N S Vasudev; P J Selby; R E Banks
Journal:  Br J Cancer       Date:  2010-06-08       Impact factor: 7.640

10.  Development of Nomograms to Predict the Recovery of Erectile Function Following Radical Prostatectomy.

Authors:  John P Mulhall; Michael W Kattan; Nelson E Bennett; Jason Stasi; Bruno Nascimento; James Eastham; Bertrand Guillonneau; Peter T Scardino
Journal:  J Sex Med       Date:  2019-09-11       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.